Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Aberrant DNA Methylation
12%
Cancer Genome Atlas
25%
Cancer Patients
25%
Clinical Information
12%
Cystectomy
12%
Delayed Diagnosis
12%
Differentially Methylated Regions
12%
DNA Methylation (DNAm)
37%
DNA Methylation Signature
100%
High Risk
12%
Independent Prognostic Factor
100%
Least Absolute Shrinkage and Selection Operator (LASSO)
25%
Low-risk Group
12%
Lymph Node Metastasis
12%
Molecular Data
12%
Multi-criteria
12%
Muscle-invasive Bladder Cancer
100%
N Stage
12%
Non-muscle Invasive
12%
Operator Analysis
12%
Operator Model
12%
Overall Survival
50%
Prognostic Accuracy
12%
Prognostic Factors
12%
Prognostic Model
12%
Prognostic Value
12%
Receiver Operating Characteristic Analysis
12%
Risk Score
75%
Smoking Status
12%
Strong Correlation
12%
T Stage
12%
Tumor
12%
Tumorigenesis
12%
Upper Tract Urothelial Carcinoma
25%
Medicine and Dentistry
Carbetimer
12%
Carcinogenesis
12%
Cystectomy
12%
DNA Methylation
100%
Low Risk Population
12%
Lymph Node Metastasis
12%
Muscle Invasive Bladder Cancer
100%
Neoplasm
12%
Overall Survival
50%
Prognostic Factor
100%
Prognostic Model
12%
The Cancer Genome Atlas
25%
Transitional Cell Carcinoma
25%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
20%
Differentially Methylated Regions
20%
DNA Methylation
100%
Low Risk Population
20%
Overall Survival
80%